Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE-20-003, Research Grants for Preventing Violence and Violence Related Injury; Amended Notice of Meeting, 14945 [2020-05257]

Download as PDF 14945 Federal Register / Vol. 85, No. 51 / Monday, March 16, 2020 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Type of respondents Form name Subject Matter Experts ................................... Focus Group/ Developmental Project Documents. Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. Prevention and the Agency for Toxic Substances and Disease Registry. [FR Doc. 2020–05314 Filed 3–13–20; 8:45 am] BILLING CODE 4163–18–P Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–05257 Filed 3–13–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE–20–003, Research Grants for Preventing Violence and Violence Related Injury; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE–20– 003, Research Grants for Preventing Violence and Violence Related Injury; April 1–2, 2020, 8:30 a.m.-5:00 p.m., EDT, in the original FRN. Embassy Suites Buckhead, 3285 Peachtree Road NE, Atlanta, GA 30305, which was published in the Federal Register on February 11, 2020, Volume 85, Number 28, pages 7760–7761. The meeting is being amended to change to a virtual meeting. The meeting is closed to the public. lotter on DSKBCFDHB2PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Kimberly Leeks, Ph.D., M.P.H., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Building 106, MS S106–9, Atlanta, Georgia 30341, telephone (770) 488–6562; KLeeks@ cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Sep<11>2014 18:29 Mar 13, 2020 Jkt 250001 Centers for Disease Control and Prevention Advisory Committee on Breast Cancer in Young Women (ACBCYW) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice of meeting. In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Advisory Committee on Breast Cancer in Young Women (ACBCYW). This meeting is open to the public, limited only by audio and web conference lines (80 audio and web conference lines are available). The public is welcome to listen to the meeting by accessing the teleconference number 1–888–606–5944, and the passcode is 8340472, (80 lines are available). The web conference access is https://adobeconnect.cdc.gov/ rwa641n3jrry/. Online Registration Required: All ACBCYW meeting participants must register for the meeting online at least 5 business days in advance at https://wwwdev.cdc.gov/ cancer/breast/what_cdc_is_doing/ conference.htm. Please complete all the required fields before submitting your registration and submit no later than May 7, 2020. DATES: The meeting will be held on May 13, 2020, from 8:00 a.m. to 1:00 p.m., EDT. SUMMARY: The teleconference access is 1–888–606–5944, and the passcode is 8340472. The web conference access is https://adobeconnect.cdc.gov/ rwa641n3jrry/. ADDRESSES: PO 00000 Frm 00074 Fmt 4703 Sfmt 9990 Number of responses per respondent 15 Average burden per response (in hours) 1 1 FOR FURTHER INFORMATION CONTACT: Jeremy McCallister, Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway NE, Mailstop S107–4, Atlanta, Georgia 30341; Telephone: (404) 639–7989, Fax: (770) 488–4760; Email: acbcyw@ cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation and evaluation of evidence-based activities designed to prevent breast cancer (particularly among those at heightened risk) and promote the early detection and support of young women who develop the disease. The advice provided by the Committee will assist in ensuring scientific quality, timeliness, utility, and dissemination of credible appropriate messages and resource materials. Matters To Be Considered: The agenda will include discussions on current topics related to breast cancer in young women. These will include Mental/ Behavioral Health, Sexual Health, Genetics and Genomics, and Provider Engagement. Agenda items are subject to change as priorities dictate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–05259 Filed 3–13–20; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\16MRN1.SGM 16MRN1

Agencies

[Federal Register Volume 85, Number 51 (Monday, March 16, 2020)]
[Notices]
[Page 14945]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05257]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CE-20-003, Research Grants for Preventing 
Violence and Violence Related Injury; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--CE-20-003, Research Grants for Preventing Violence and Violence 
Related Injury; April 1-2, 2020, 8:30 a.m.-5:00 p.m., EDT, in the 
original FRN.
    Embassy Suites Buckhead, 3285 Peachtree Road NE, Atlanta, GA 30305, 
which was published in the Federal Register on February 11, 2020, 
Volume 85, Number 28, pages 7760-7761.
    The meeting is being amended to change to a virtual meeting. The 
meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Kimberly Leeks, Ph.D., M.P.H., 
Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, 
Building 106, MS S106-9, Atlanta, Georgia 30341, telephone (770) 488-
6562; [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-05257 Filed 3-13-20; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.